- Home
- SGHT vs NUW Comparison
SGHT vs NUW Comparison
Compare SGHT & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- NUW
- Stock Information
- Founded
- SGHT 2011
- NUW 2008
- Country
- SGHT United States
- NUW United States
- Employees
- SGHT 216
- NUW N/A
- Industry
- SGHT Medical Specialities
- NUW Investment Managers
- Sector
- SGHT Health Care
- NUW Finance
- Exchange
- SGHT Nasdaq
- NUW Nasdaq
- Market Cap
- SGHT 179.7M
- NUW 245.0M
- IPO Year
- SGHT 2021
- NUW N/A
- Fundamental
- Price
- SGHT $3.64
- NUW $13.67
- Analyst Decision
- SGHT Buy
- NUW
- Analyst Count
- SGHT 8
- NUW 0
- Target Price
- SGHT $4.01
- NUW N/A
- AVG Volume (30 Days)
- SGHT 164.1K
- NUW 45.3K
- Earning Date
- SGHT 07-31-2025
- NUW 01-01-0001
- Dividend Yield
- SGHT N/A
- NUW 3.66%
- EPS Growth
- SGHT N/A
- NUW N/A
- EPS
- SGHT N/A
- NUW N/A
- Revenue
- SGHT $78,109,000.00
- NUW N/A
- Revenue This Year
- SGHT N/A
- NUW N/A
- Revenue Next Year
- SGHT $11.60
- NUW N/A
- P/E Ratio
- SGHT N/A
- NUW N/A
- Revenue Growth
- SGHT N/A
- NUW N/A
- 52 Week Low
- SGHT $2.03
- NUW $12.45
- 52 Week High
- SGHT $8.45
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- SGHT 38.36
- NUW 50.64
- Support Level
- SGHT $3.37
- NUW $13.63
- Resistance Level
- SGHT $3.60
- NUW $13.85
- Average True Range (ATR)
- SGHT 0.23
- NUW 0.11
- MACD
- SGHT -0.12
- NUW -0.00
- Stochastic Oscillator
- SGHT 8.21
- NUW 41.94
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.